10x Genomics, Inc. is trading at $28.40 (-2.44%) after retreating from a post-deal rally following its acquisition of Proteintech Genomics.
- Shares are giving back gains from the prior session's sharp move higher triggered by the deal announcement.
- The decline appears to be company-specific, as broader market indices are currently trading mixed-to-higher.